Search results
Results from the WOW.Com Content Network
Alipogene tiparvovec (Glybera): AAV-based treatment for lipoprotein lipase deficiency (no longer commercially available); Axicabtagene ciloleucel (Yescarta): treatment for large B-cell lymphoma [1]
Arizona. Translational Genomics Research Institute; California. Clear Labs; Genetic Information Research Institute; Joint Genome Institute (U.S. Department of Energy); Salk Institute for Biological Studies
India is the world's largest vaccine maker as of 2020. [18] Indian vaccine manufactures include the Serum Institute of India (SII). [19] SII is the world's largest vaccine manufacturer. [20] [21] Reliance Life Sciences, among other products, also manufactures vaccines. [22] [23] Another established vaccine manufacturer is Bharat Biotech. [24]
The gene therapies market is experiencing significant growth, driven by advancements in research and technology. According to DelveInsight, the gene therapy clinical trial pipeline features over 180 key companies actively engaged in the development of more than 200 gene therapies.
For more companies, take a look at 5 Most Promising Gene Therapy Companies to Watch. Gene therapy is a revolutionary new technology that has followed the growing advances in computing power. The ...
Genome Valley is an Indian high-technology business district spread across 2,000-acre (8.1 km 2)/(3.1 sq mi) in Hyderabad, India. [ 1 ] [ 2 ] It is located across the suburbs, Turakapally , Shamirpet , Medchal , Uppal , Patancheru , Jeedimetla , Gachibowli and Keesara .
Adverum Biotechnologies, Inc., formerly known as Avalanche Biotechnologies, [2] is a publicly traded [3] clinical stage gene therapy company located in Redwood City, California. [4] The company is targeting unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration (wet AMD).
The company was founded in 1976 by venture capitalist Robert A. Swanson and biochemist Herbert Boyer. [ 9 ] [ 10 ] Boyer is considered to be a pioneer in the field of recombinant DNA technology. In 1973, Boyer and his colleague Stanley Norman Cohen demonstrated that restriction enzymes could be used as "scissors" to cut DNA fragments of ...